89 related articles for article (PubMed ID: 18035721)
1. [Identification of cytochromes P450 in the human liver microsomes by mass spectrometry].
Petushkova NA; Lisitsa AV; Karuzina II; Zgoda VG; Sheremet'eva GF; Samenkova NF; Nikitin IP; Sakharova TA; Kopylov AT; Archakov AI
Biomed Khim; 2007; 53(4):400-11. PubMed ID: 18035721
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human liver cytochromes P450 by combining the biochemical and proteomic approaches.
Petushkova NA; Kanaeva IP; Lisitsa AV; Sheremetyeva GF; Zgoda VG; Samenkova NF; Karuzina II; Archakov AI
Toxicol In Vitro; 2006 Sep; 20(6):966-74. PubMed ID: 16533590
[TBL] [Abstract][Full Text] [Related]
3. Proteomic and biochemical analysis of the mouse liver microsomes.
Kanaeva IP; Petushkova NA; Lisitsa AV; Lokhov PG; Zgoda VG; Karuzina II; Archakov AI
Toxicol In Vitro; 2005 Sep; 19(6):805-12. PubMed ID: 15908171
[TBL] [Abstract][Full Text] [Related]
4. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes.
Yamazaki H; Inoue K; Mimura M; Oda Y; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Feb; 51(3):313-9. PubMed ID: 8573198
[TBL] [Abstract][Full Text] [Related]
5. [Study of the mouse liver microsomes by the methods of proteome analysis].
Kanaeva IP; Petushkova NA; Lokhov PG; Zgoda VG; Karuzina II; Lisitsa AV; Archakov AI
Biomed Khim; 2004; 50(4):367-75. PubMed ID: 15518183
[TBL] [Abstract][Full Text] [Related]
6. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A
Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
8. Catalytic and immunochemical characterization of hepatic microsomal cytochromes P450 in beluga whale (Delphinapterus leucas).
White RD; Hahn ME; Lockhart WL; Stegeman JJ
Toxicol Appl Pharmacol; 1994 May; 126(1):45-57. PubMed ID: 8184432
[TBL] [Abstract][Full Text] [Related]
9. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
10. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
11. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome
Kim D; Kim V; Tateishi Y; Guengerich FP
Drug Metab Dispos; 2021 Oct; 49(10):902-909. PubMed ID: 34330716
[TBL] [Abstract][Full Text] [Related]
13. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
14. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
15. Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat.
Thal C; el Kahwaji J; Loeper J; Tinel M; Doostzadeh J; Labbe G; Leclaire J; Beaune P; Pessayre D
J Pharmacol Exp Ther; 1994 Jan; 268(1):515-21. PubMed ID: 8301593
[TBL] [Abstract][Full Text] [Related]
16. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
17. Computational approach to characterization of human liver drug-metabolizing enzymes.
Petushkova NA; Pyatnitskiy MA; Lisitsa AV; Larina OV; Kuznetsova GP; Skipenko OG; Karuzina II; Archakov AI
Eur J Pharm Sci; 2010 Oct; 41(2):305-11. PubMed ID: 20599500
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytochrome P450-dependent monooxygenases in hamster tissues by fasting.
Ueng TH; Ueng YF; Chen TL; Park SS; Iwasaki M; Guengerich FP
Toxicol Appl Pharmacol; 1993 Mar; 119(1):66-73. PubMed ID: 8470125
[TBL] [Abstract][Full Text] [Related]
19. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
20. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
Goosen TC; Mills DE; Hollenberg PF
J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
